NEW YORK–(BUSINESS WIRE)–Accolade Health, Inc. (“Accolade”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that on June 8, 2022 the Compensation Committee of Accolade’s Board of Directors approved the grant of inducement restricted stock unit awards covering 992,382 Class A shares of Accolade’s common stock to 29 new … [Read more…]
LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. … [Read more…]
NEW YORK & BOSTON & WILMINGTON, Del.–(BUSINESS WIRE)–Pfizer Inc. (NASDAQ:PFE), MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: MOR; NASDAQ:MOR), and Incyte (NASDAQ:INCY) today announced a clinical trial collaboration and supply agreement to investigate the immunotherapeutic combination of Pfizer’s TTI-622, a novel SIRPα-Fc fusion protein, and Monjuvi® (tafasitamab-cxix) plus lenalidomide in patients … [Read more…]
Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration’s (FDA) review and clearance of a 510(k) the … [Read more…]
SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for our Annual Meeting to provide a … [Read more…]
Largest Gift in the Organization’s 112-year History Helps Assure That Children With a Musculoskeletal Condition or Injury Have the Opportunity to Grow Well and Play Well LOS ANGELES–(BUSINESS WIRE)–#luskin–Orthopaedic Institute for Children announced today that it has received a $15 million gift from Renee & Meyer Luskin, the largest gift to the organization’s endowment in … [Read more…]
– Newly Appointed Members Include Judith Campisi, Ph.D., Mario Lacouture, M.D. and Francesca Grisoni, Ph.D. SUNNYVALE, Calif.–(BUSINESS WIRE)–Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies for chronic age-related diseases targeting senescent cells that drive cellular aging, today announced the appointments of Judith Campisi, Ph.D., Francesca Grisoni, Ph.D., and Mario Lacouture, M.D., to … [Read more…]
This randomized, placebo-controlled Phase II clinical study with TOTUM•070 achieved its objective of reducing LDL cholesterol (primary endpoint) and confirmed the very good tolerance of this active substance. As early as 3 months of supplementation, the results showed a significant reduction in blood levels of LDL cholesterol (-13%) and triglycerides (-14%). Comprehensive data from the … [Read more…]
New facility will double the occupancy of the current rehabilitation center ARROYO GRANDE, Calif.–(BUSINESS WIRE)–Arroyo Grande Community Hospital (AGCH) and Kindred Rehabilitation Services (KRS), a business unit of LifePoint Health, today announced a joint venture to build and operate a new inpatient rehabilitation hospital on Dignity Health’s Arroyo Grande Community Hospital campus. The approximately 46,000-square-foot … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2022” conference has been added to ResearchAndMarkets.com’s offering. The Global Clinical Trials Connect 2022 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This event is designed for senior-level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution providers … [Read more…]
